MedTrace Logo

Fox Investigation for New Discovery of Biomarkers

NCT01705327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2015-10-05

No results posted yet for this study

Summary

This is an observational, multi-center study to assess clinical features and biologic biomarkers in Parkinson's disease (PD) patients compared to healthy controls (HC). The primary objective of this study is to discover clinical and biologic markers of PD for use in clinical trials of disease-modifying therapies.

Conditions

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Michael J. Fox Foundation for Parkinson's Research

    lead OTHER

Principal Investigators

  • Jennifer Goldman, MD, MS · Rush University Medical Center

  • Roy Alcalay, MD, MS · Columbia University

  • Claire Henchcliffe, MD, D. Phil · Well Cornell Medical Center

  • Tao Xie, MD, PhD · University of Chicago

  • Paul Tuite, MD · University of Minnesota Medical Center

  • Un Jung Kang, MD · University of Chicago

  • Cindy Casaceli, MBA · Clinical Trial Coordinating Center, University of Rochester

  • Penelope Hogarth, MD · Oregon Health and Science University

  • Samuel A. Frank, MD · Boston Medical Center

  • Amy Amara, MD, PhD · University of Alabama at Birmingham

Eligibility

Min Age
55 Years
Max Age
93 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01705327 on ClinicalTrials.gov